What the buyer wrote
The East of England molecular unit based in Cambridge relies on a fleet of rotor-gene platforms to run the vast majority of molecular assays. The total number of these instruments in the Cambridge lab stands at 13 but 3 are of a now obsolete model. The PHE Capital group have approved funding to replace these instruments.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Replacement Rotor-Gene Platforms
- How they are buying
- The buyer did not say
- Type
- services
- Work starts
- 7 Dec 2015
- Work ends
- 7 Dec 2016
Who the buyer named
The buyer published a contact address on this notice.